Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia


Yalçın C., Özkalemkaş F., Özkocaman V., Ersal T., Pınar İ. E., Orhan B., ...More

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, vol.14, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14
  • Publication Date: 2022
  • Doi Number: 10.4084/mjhid.2022.039
  • Journal Name: MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, Directory of Open Access Journals
  • Keywords: Empiric glycopeptide, Febrile neutropenia, Hematologic malignancy, INFECTIOUS-DISEASES SOCIETY, BLOOD-STREAM INFECTIONS, ACUTE MYELOID-LEUKEMIA, CANCER-PATIENTS, MORTALITY, VANCOMYCIN, CHEMOTHERAPY, EPIDEMIOLOGY, MANAGEMENT, FREQUENCY
  • Bursa Uludag University Affiliated: Yes

Abstract

Background: This study aimed to evaluate the effects of the appropriate use of empiric glycopeptide therapy in hematologic malignancy patients with febrile neutropenia (FN).